Difference between revisions of "Steatohepatitis"

From Libre Pathology
Jump to navigation Jump to search
Line 72: Line 72:


===Grading steatohepatitis===
===Grading steatohepatitis===
Grading inflammation:<ref name=pmid10484010>{{Cite journal  | last1 = Brunt | first1 = EM. | last2 = Janney | first2 = CG. | last3 = Di Bisceglie | first3 = AM. | last4 = Neuschwander-Tetri | first4 = BA. | last5 = Bacon | first5 = BR. | title = Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. | journal = Am J Gastroenterol | volume = 94 | issue = 9 | pages = 2467-74 | month = Sep | year = 1999 | doi = 10.1111/j.1572-0241.1999.01377.x | PMID = 10484010 }}</ref>
====Brunt grading system====
*Grade 1 - steatosis, [[PMN]]s, occasional ballooning degeneration. ‡
Grading system proposed by Brunt in 1999:<ref name=pmid10484010>{{Cite journal  | last1 = Brunt | first1 = EM. | last2 = Janney | first2 = CG. | last3 = Di Bisceglie | first3 = AM. | last4 = Neuschwander-Tetri | first4 = BA. | last5 = Bacon | first5 = BR. | title = Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. | journal = Am J Gastroenterol | volume = 94 | issue = 9 | pages = 2467-74 | month = Sep | year = 1999 | doi = 10.1111/j.1572-0241.1999.01377.x | PMID = 10484010 }}</ref>
*Grade 2 - obvious ballooning, obvious PMNs, chronic inflammation.
{| class="wikitable sortable" style="text-align: center
*Grade 3 - panacinar steatosis.
! Grade
 
! Characteristics
|-
| 1  
| steatosis, [[PMN]]s, occasional ballooning degeneration ‡
|-
| 2  
| obvious ballooning, obvious PMNs, chronic inflammation
|-
| 3  
| panacinar steatosis
|}
Note:
Note:
*‡ Ballooning may be absent.<ref name=pmid10484010/>  
*‡ Ballooning may be absent.<ref name=pmid10484010/>  
====Clinical Research Network system====
Nonalcoholic steatohepatitis Clinical Research Network system for scoring activity - adapted from Brunt and Tiniakos:<ref name=pmid21072891>{{Cite journal  | last1 = Brunt | first1 = EM. | last2 = Tiniakos | first2 = DG. | title = Histopathology of nonalcoholic fatty liver disease. | journal = World J Gastroenterol | volume = 16 | issue = 42 | pages = 5286-96 | month = Nov | year = 2010 | doi =  | PMID = 21072891 }}</ref>
{| class="wikitable sortable" style="text-align: center
! Score
! Steatotic <br>hepatocytes (%)
! Lobular <br>lymphocytes
! Ballooning <br>heptocytes
|-
| 0
| <5%
| none
| none
|-
| 1
| 5-33%
| <2
| few
|-
| 2
| 34%-66%
| 2-4
| many
|-
| 3
| >66%
| >4
| (not assigned)
|}


====Images====
====Images====

Revision as of 03:09, 17 June 2016

Steatohepatitis
Diagnosis in short

Steatohepatitis. Trichrome stain.
LM steatosis (usually macrovesicular); hepatocyte injury -- ballooning degeneration (key feature), Mallory bodies; portal bridging (late stage)
Subtypes by etiology (classically): ASH, NASH -- all almost histologically identical
LM DDx steatosis, Wilson disease, hepatitis C, drug-induced liver disease
Gross pale/yellowish, often enlarged
Site liver - see medical liver disease
Associated Dx obesity, alcohol abuse
Prevalence common
Prognosis dependent on underlying cause
Treatment dependent on underlying cause

Steatohepatitis is a fatty change of the liver (steaosis) with (histologic) evidence of liver injury. It can be due to a number of different causes.

General

  • Steatohepatitis is a label for a set of histopathologic findings.
  • Fat accumulation (in hepatocytes) alone is liver steatosis.
    • It may be a pattern seen in drug toxicity, e.g. methotrexate toxicity.[1]

Etiology:

  1. Alcohol = alcoholic steatohepatitis (ASH).
  2. Not alcohol = non-alcoholic steatohepatitis (NASH).
  3. Drug/toxin.[2]

Notes:

  • Pathologists can comment on the etiology; however, the histomorphology is not distinctive. In other words, ASH and NASH are clinical diagnoses.
  • Steatohepatitis is a misnomer. It is not an -itis; inflammation is not the (predominant) pathologic process.

Microscopic

Features:

  • Steatosis (usually macrovesicular) - key feature.
    • If less than 10% ... consider alt. diagnosis/disease process.
  • Hepatocyte injury:
    • Ballooning degeneration - key feature. †
    • Mallory bodies.
      • Mallory body wannabes: "occasional cytoplasmic clumping".
  • +/-Chicken-wire perisinusoidal fibrosis +/- zone III (centrilobular) fibrosis (early).
    • Late-stage disease - portal bridging.[3]

Note:

  • † Brunt does not require ballooning to be present to call steatohepatitis;[4] however, a table in a later paper Brunt paper (surveying pathologists) suggest that a significant number of pathologist may consider it a required finding.[5]

DDx:

Image

  • Steatohepatitis. (WC)

Grading steatohepatitis

Brunt grading system

Grading system proposed by Brunt in 1999:[4]

Grade Characteristics
1 steatosis, PMNs, occasional ballooning degeneration ‡
2 obvious ballooning, obvious PMNs, chronic inflammation
3 panacinar steatosis

Note:

  • ‡ Ballooning may be absent.[4]

Clinical Research Network system

Nonalcoholic steatohepatitis Clinical Research Network system for scoring activity - adapted from Brunt and Tiniakos:[6]

Score Steatotic
hepatocytes (%) 		Lobular
lymphocytes 		Ballooning
heptocytes
0 <5% none none
1 5-33% <2 few
2 34%-66% 2-4 many
3 >66% >4 (not assigned)


Images

Fibrosis stage 0 Brunt necroinflammatory grade 1 (WC)
 Necroinflammatory grades Brunt 1, NAH 3. Fibrosis stage 0. About 25% of the liver shows steatosis (UL), not pan-acinar. Only rarely identified were either ballooned hepatocytes or inflammatory aggregates. UR shows more macrovesicular (blue arrowhead) than microvesicular (yellow arrowhead) steatosis, with occasional neutrophils in acini ( tip of green arrowhead, benath inflammatory aggregate, with tuft of material in ballooned hepatocyte at base of green arrow), and many glycogenated nuclei (magenta arrowhead). Additional evidence of hepatocellular damage is seen on the reticulin with focal zone III collapse (LL, blue arrowhead) and on the PAS with diastase stain with PAS-D Kupffer cells (LR black arrowheads)

Original oculars. UL 4X. UR 40X, LL 40X, LR 40X

Fibrosis stage 1 Brunt necroinflammatory grade 2 (WC)
 Necroinflammatory grades Brunt 2, NAH 6. Fibrosis stage 1. About half the hepatocytes show macrovesicular steatosis (UL), with sparing of part of the acinus (UL, Black arrowhead), Lipogranulomas, acomar inflammatory collections, mostly macrophages, about steatosis/ballooning degeneration afflicted hepatocytes or adjacent to them (UR, green arrowheads) are present.Tufts/flocks of ballooning degeneration are readily found (LL, magenta arrowheads). Mild to moderate mononuclear inflammation of portal triads does not exclude steatohepatitis (LL, yellow arrowheads). Trichrome displays the blue thin lines that separate hepatocytes in stage 1 fibrosis (LR blue arrowheads). Original oculars UL 4X, UR 40X (higher pixel photograph), LL 40X , LR 10X
Fibrosis stage 2 Brunt necroinflammatory grade 1 (WC)
 Necroinflammatory grades Brunt 1, NAH 3. Fibrosis stage 2. Overall, about a third of the biopsy shows mostly macrovesicular steatosis (UL). Rare inflammatory aggregates and ballooned hepatocytes were seen, but occasional linear/ropy Mallory hyalin was seen (UR blue arrowhead). Although trichrome can highlight Mallory hyalin (LL red arrowhead), the remainder of the image shows other cytoplasmic collections will also stain blue/blue-grey. The trichrome stain also showed peri-portal fibrosis (LR, yellow arrowheads). Original oculars UL 4X, UR 40X (higher pixel photograph), LL 40X (higher pixel photograph), LR 20X
Fibrosis stage 3 Brunt necroinflammatory grade 2 (WC)
 Necroinflammatory grades Brunt 2, NAH 7. Fibrosis stage 3. About 70% of hepatocytes are afflicted by steatosis (UL). Many ballooned cells are present, with their residual tufts/flocks (UR green arrowheads) demarcating multiple cells having formed apparent fat cysts. Two-three acinar inflammatory foci (UL magenta arrowheads) can be seen in a 20X field. The disorder is emphasized by a reticulin stain which shows the thin black lines (LL blue arrowheads) forming acinar circles, heading in irregular directions, and coming closer and separating from adjacent lines with great variability. The trichrome stain (RL) shows a bridge. Original oculars UL 4X, UR 20X, LL 20X, LR 10X
Fibrosis stage 4 Brunt necroinflammatory grade 3 (WC)
 Necroinflammatory grades Brunt 3, NAH 8. Fibrosis stage 4. Steatosis is pan-acinar (UL). Acinar inflammatory aggregates More than 4 inflammatory aggregates are seen in a 20X field (UR black arrowheads). Many cells show ballooning degeneration, with tufts/flocks of material cytoplasm (LL yellow arrowheads) Trichrome limns regenerative nodules (LR magenta arrowheads). Original oculars UL 4X, UR 20X, LL 40X (higher pixel photograph), LR 10X

See also

References

  1. ↑ MG. 22 September 2009.
  2. ↑ Farrell, GC. (2002). "Drugs and steatohepatitis.". Semin Liver Dis 22 (2): 185-94. doi:10.1055/s-2002-30106. PMID 12016549.
  3. ↑ Gramlich, T.; Kleiner, DE.; McCullough, AJ.; Matteoni, CA.; Boparai, N.; Younossi, ZM. (Feb 2004). "Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.". Hum Pathol 35 (2): 196-9. PMID 14991537.
  4. ↑ 4.0 4.1 4.2 Brunt, EM.; Janney, CG.; Di Bisceglie, AM.; Neuschwander-Tetri, BA.; Bacon, BR. (Sep 1999). "Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.". Am J Gastroenterol 94 (9): 2467-74. doi:10.1111/j.1572-0241.1999.01377.x. PMID 10484010.
  5. ↑ Brunt, EM. (2001). "Nonalcoholic steatohepatitis: definition and pathology.". Semin Liver Dis 21 (1): 3-16. PMID 11296695.
  6. ↑ Brunt, EM.; Tiniakos, DG. (Nov 2010). "Histopathology of nonalcoholic fatty liver disease.". World J Gastroenterol 16 (42): 5286-96. PMID 21072891.
Retrieved from "https://librepathology.org/w/index.php?title=Steatohepatitis&oldid=45030"